Oncology
Exploring next-generation targeted therapies, including antibody-drug conjugate (ADC) approaches and targeted oral therapies, aimed at improving precision and patient outcomes in complex cancers.
Research & development · CRO
From molecule to market — under one roof.
Apex Evergreen is more than a manufacturer. Through in-house research and a dedicated Contract Research Organization, we take medicines from early discovery, through clinical development, to commercial-scale supply — a rare end-to-end partnership in global pharmaceuticals.
End to end
The integrated journey.
- 01 Discovery Scouting and evaluating new molecules and technologies.
- 02 Development & formulation Turning candidates into stable, manufacturable dosage forms.
- 03 Clinical trials (CRO) Designing and running trials across all phases.
- 04 Regulatory & registration Preparing dossiers and securing approvals.
- 05 Commercial manufacturing Scaling to commercial supply across 21 facilities.
- 06 Global supply Delivering to patients across 80+ markets.
Research & development
Where our research is heading.
Research is never static. We continuously scout, evaluate, and develop new molecules and delivery technologies across our therapeutic segments — pursuing the science shaping the next generation of medicine.
Cardiovascular & metabolic
Developing advanced lipid-management approaches (including PCSK9 and siRNA-based strategies) and next-generation therapies in the fast-evolving metabolic and diabetes space, including GLP-1 receptor agonist science.
Advanced drug delivery
Focused on long-acting injectable technologies (biodegradable microsphere and in-situ depot systems), sustained-release ophthalmic delivery, and precision intranasal delivery — extending our core formulation strengths.
Anti-infectives
Pursuing new-approach anti-infective and antibiotic development, an urgent global health priority as resistance grows.
Paediatric & specialty formulations
Developing patient-centric formulations — including taste-masked, dispersible, and climate-stable forms — tailored to the diverse markets we serve.
Technology-enabled discovery
Integrating modern computational and AI-assisted approaches to accelerate molecule identification and formulation development.
Research focus areas reflect our areas of active interest and development; they do not represent approved products or claims of specific clinical status.
Contract research organization
A full-service research partner.
Our dedicated CRO supports pharmaceutical and biotech partners across the entire clinical development journey — with the rigor, quality systems, and global regulatory experience that define Apex Evergreen.
Clinical trials (Phase I–IV)
End-to-end clinical trial design, conduct, and management across all phases.
Bioequivalence & BA/BE studies
Bioavailability and bioequivalence studies to support generic and hybrid development.
Bioanalytical services
Method development, validation, and sample analysis to international standards.
Clinical operations & project management
Site management, monitoring, and coordination across multiple geographies.
Regulatory & dossier support
Regulatory strategy, submissions, and dossier preparation for global markets.
Formulation & analytical development
Formulation, analytical method development, and stability studies.
Pharmacovigilance & safety
Drug safety monitoring and pharmacovigilance support.
Why Apex Evergreen
One partner. The whole journey.
Few organizations bring discovery, clinical research, manufacturing, and global registration together under a single group. With in-house R&D, a full-service CRO, 21 manufacturing facilities, and registrations across 80+ markets, Apex Evergreen removes the hand-offs between separate vendors — compressing timelines, reducing risk, and giving partners one accountable team from molecule to market.
-
Fewer hand-offs
One accountable partner from discovery to delivery.
-
Faster timelines
Parallel workflows across research, development, and manufacturing.
-
Lower risk
Integrated quality systems and regulatory experience across 80+ markets.
-
Global reach
Registration and supply capabilities spanning six continents.
Advance your molecule
Advance your molecule with us.
From first discovery to global supply, our research and CRO teams are ready to move your programme forward.